Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 Plus Irinotecan in Advanced Gastric Cancer
NCT00209664Phase 2Suspended
- Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur, irinotecan in gastric cancer (GC), sponsored by Hokkaido Gastrointestinal Cancer Study Group. Started Jan 2004; status: suspended.
02
Drugs
tegafuririnotecan
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00209664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209664.